Semaglutide Intermediate P29 Powder, GLP-1 Cas No.1169630-82-3
Product source: Chemical Synthesis
Content specification: ≥ 95% (HPLC)
CAS NO:1169630-82-3
Detection methods: HPLC, LC-MS
Active ingredient: GLP-1 (9-37)
Product mesh: 100-200 mesh
Product Description: White or off white powder;Has hygroscopicity.
Product Usage: Used for the production of semaglutide
Product packaging: 1g, 5g, 10g, 25g, 50g, 100g, etc
Product storage: Store in a sealed, dark, and dry environment at -20 ° C or lower temperatures (such as -80 ° C).
Shelf life: 24 months
Semaglutide Intermediate P29 (GLP-1 9-37) API
CAS 1169630-82-3 | Pharmaceutical-Grade Synthetic Peptide | SPPS Manufacturing
⚠️ REGULATORY COMPLIANCE & B2B MANUFACTURING: This peptide intermediate is strictly supplied as a bulk raw material for B2B industrial pharmaceutical manufacturing and commercial API synthesis. It is NOT a finished therapeutic product. Xi'an Tihealth guarantees sequence fidelity and GMP-aligned traceability for drug substance CMC regulatory filings.
Strategic Backbone for Semaglutide Synthesis
The P29 intermediate (GLP-1 9-37) is the fundamental peptide sequence required for industrial Semaglutide manufacturing. Xi'an Tihealth Biotechnology Co., Ltd. utilizes high-precision Solid-Phase Peptide Synthesis (SPPS) to guarantee absolute sequence fidelity.
We rigorously manage the deletion sequence profile to ensure that your downstream Lys26 acylation and therapeutic conjugation reactions achieve maximum conversion yields. Our production delivers a Non-Animal Origin (NAO) peptide that is fully traceable, minimizing regulatory friction during formulation development.
Technical Specification (TDS Profile)
| Testing Parameter | Tihealth Specification Limits |
|---|---|
| Product Name | Semaglutide Intermediate P29 (GLP-1 9-37) |
| CAS Registry Number | 1169630-82-3 |
| Sequence | GLP-1(9-37) |
| Assay (HPLC Purity) | ≥ 95.0% |
| Synthesis Method | SPPS (Non-Animal Origin) |
| Appearance | White Hygroscopic Powder |
| Storage Stability | -20°C (Requires moisture-proof vacuum sealing) |
* Comprehensive impurity profiling via LC-MS and sequence composition data are dispatched with commercial orders to support global CMC submissions.
Synthesis & Formulation Advantages
- Optimized for Lys26 Acylation: Our P29 backbone provides the exact architectural accessibility required for the site-specific conjugation of the C18 fatty diacid side chain, a critical step in finalizing the Semaglutide therapeutic profile.
- High-pH Solubility Profile: Engineered for superior solubility in alkaline media (pH 11.0–11.5). This ensures a clean, monomeric reaction solution, actively preventing peptide aggregation and increasing overall coupling efficiency during downstream synthesis.
- Regulatory Ready (CMC Support): Provided with a complete technical dossier, including structural elucidation and residual solvent verification, to seamlessly integrate into your quality management systems.
Regulatory & Handling Transparency FAQ
How do you validate the GLP-1 (9-37) sequence integrity?
We utilize high-resolution Liquid Chromatography-Mass Spectrometry (LC-MS) to verify precise molecular weight, alongside Amino Acid Analysis (AAA) to confirm the exact sequence composition. This multi-layered analytical approach ensures the 29-residue peptide matches the target sequence identically, completely free from truncated or deletion byproducts.
What is the mandatory storage condition for the P29 intermediate?
P29 is extremely hygroscopic and temperature-sensitive. It must be stored at -20°C (or -80°C for long-term inventory stability). It should be kept strictly in a vacuum-sealed, moisture-proof environment. To guarantee structural integrity upon arrival, we execute specialized cold-chain shipping protocols packed with dry ice for all international bulk consignments.
Ready to Source Validated Semaglutide Intermediates?
Contact our technical sales director for bulk pricing, custom purity protocols, and full analytical dossiers (COA/MSDS).
👤 Technical Director: Wang Xueyan
📧 peter@xatihealth.com
📞 WhatsApp: +86 13991246876
Hot Tags: Semaglutide Intermediate P29 Powder, GLP-1 Cas No.1169630-82-3, China Semaglutide Intermediate P29 Powder, GLP-1 Cas No.1169630-82-3 manufacturers, suppliers, factory, hialuronato de sodio hialuronato sodico sodium hyaluronate, , ,
You Might Also Like
Send Inquiry








